The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A proteolytic system that compensates for loss of proteasome function
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,357
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution
Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,525
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,410
Empty MHC class I molecules come out in the cold
Ljunggren, H.-G., Stam, N. J., Öhlén, C., Neefjes, J. J., Höglund, P., Heemels, M.-T., Bastin, J., Schumacher, T. N. M., Townsend, A., Kärre, K., et al. (1990) · Nature · doi:10.1038/346476a0 · Cited by 926
Self-citationKing, R. W., Jackson, P. K., & Kirschner, M. W. (1994) · Cell · doi:10.1016/0092-8674(94)90542-8 · Cited by 738
Cited by
Items 101–200 of 270
Stavropoulou, V., Xie, J., Arsenian‐Henriksson, M., Tomkinson, B., Imreh, S., & Masucci, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2085 · Cited by 59
Morphine Induces Ubiquitin-Proteasome Activity and Glutamate Transporter Degradation
Yang, L., Wang, S., Sung, B., Lim, G., & Mao, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800809200 · Cited by 57
Tripeptidyl Peptidase II. An Oligomeric Protease Complex from Arabidopsis
Book, A. J., Yang, P., Scalf, M., Smith, L. M., & Vierstra, R. D. (2005) · PLANT PHYSIOLOGY · doi:10.1104/pp.104.057406 · Cited by 64
IFN-γ Exposes a Cryptic Cytotoxic T Lymphocyte Epitope in HIV-1 Reverse Transcriptase
Sewell, A. K., Price, D. A., Moins‐Teisserenc, H., Booth, B. L., Gileadi, U., Flavin, F. M., Trowsdale, J., Phillips, R. E., & Cerundolo, V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7075 · Cited by 57
Kraus, M., Bader, J. E., Overkleeft, H. S., & Driessen, C. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.2 · Cited by 58
Kraus, M., Müller-Ide, H., Rückrich, T., Bader, J. E., Overkleeft, H. S., & Driessen, C. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.12.017 · Cited by 56
Guil, S., Rodríguez-Castro, M., Aguilar, F., Villasevil, E. M., Antón, L. C., & Val, M. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608522200 · Cited by 54
Pettigrew, G. J., Lovegrove, E., Bradley, J. A., Maclean, J., & Bolton, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1292 · Cited by 54
Hamouda, M.-A., Belhacène, N., Puissant, A., Colosetti, P., Robert, G., Jacquel, A., Mari, B. P., Auberger, P., & Luciano, F. (2014) · Oncotarget · doi:10.18632/oncotarget.2193 · Cited by 54
Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
Maxwell, S. A., & Mousavi-Fard, S. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213498985 · Cited by 51
Franklin, J. L., & Johnson, E. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.5.1313 · Cited by 51
Epstein–Barr virus oncogenesis and the ubiquitin–proteasome system
Masucci, M. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207372 · Cited by 51
Small-Molecule Inhibitors of Proteasome Activity
Gaczynska, M. E., & Osmulski, P. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-895-1:003 · Cited by 50
Self-citationVal, M. D., & López, D. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00104-9 · Cited by 49
Fayadat, L., Siffroi‐Fernandez, S., Lanet, J., & Franc, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m905763199 · Cited by 49
Combined Effect of Proteasome and Calpain Inhibition on Cisplatin-Resistant Human Melanoma Cells
Młynarczuk-Biały, I., Röckmann, H., Kuckelkorn, U., Schmidt, B., Umbreen, S., Gołąb, J., Ludwig, A., Montag, C., Wiebusch, L., Hagemeier, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2614 · Cited by 54
Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands
Wei, J., Zanker, D. J., Carluccio, A. R. D., Smelkinson, M. G., Takeda, K., Seedhom, M. O., Dersh, D., Gibbs, J. S., Yang, N., Jadhav, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602122 · Cited by 48
Encore facilitates SCF-Ubiquitin-proteasome-dependent proteolysis duringDrosophilaoogenesis
Ohlmeyer, J. T., & Schüpbach, T. (2003) · Development · doi:10.1242/dev.00855 · Cited by 48
Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes
Vigneron, N., & den Eynde, B. J. V. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0658-x · Cited by 46
Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition
Naujokat, C., Fuchs, D., & Berges, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.007 · Cited by 57
Smyth, K., & Belote, J. M. (1999) · Genetics · doi:10.1093/genetics/151.1.211 · Cited by 46
Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo
Grossmann, M. E., Madden, B. J., Gao, F., Pang, Y., Carpenter, J. E., McCormick, D., & Young, C. Y. F. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.030 · Cited by 45
The processing of antigens delivered as DNA vaccines
Howarth, M. R., & Elliott, T. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00141.x · Cited by 45
Re-evaluating the Generation of a “Proteasome-Independent” MHC Class I-Restricted CD8 T Cell Epitope
Wherry, E. J., Golovina, T. N., Morrison, S. E., Sinnathamby, G., McElhaugh, M. J., Shockey, D. C., & Eisenlohr, L. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2249 · Cited by 44
Hilbi, H., Puro, R. J., & Zychlinsky, A. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5502-5508.2000 · Cited by 44
Tu, L., Moriya, C., Imai, T., Ishida, H., Tetsutani, K., Duan, X., Murata, S., Tanaka, K., Shimokawa, C., Hisaeda, H., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200839117 · Cited by 43
Giant proteases: Beyond the proteasome
Yao, T., & Cohen, R. E. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80352-2 · Cited by 43
Proteasome inhibitors: fromin vitro uses to clinical trials
Rivett, A. J., & Gardner, R. C. (2000) · Journal of Peptide Science · doi:10.1002/1099-1387(200009)6:9<478::aid-psc285>3.0.co;2-f · Cited by 43
Five Questions (with their Answers) on ER ‐Associated Degradation
Pisoni, G. B., & Molinari, M. (2016) · Traffic · doi:10.1111/tra.12373 · Cited by 42
A giant protease with a twist: the TPP II complex from Drosophila studied by electron microscopy
Rockel, B., Peters, J., Kühlmorgen, B., Glaeser, R. M., & Baumeister, W. P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf601 · Cited by 42
The Proteasome Is Required for Rapid Initiation of Death Receptor-Induced Apoptosis
Sohn, D., Totzke, G., Eßmann, F., Schulze‐Osthoff, K., Levkau, B., & Jänicke, R. U. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1967-1978.2006 · Cited by 48
Vlashi, E., Lagadec, C. H., Chan, M., Frohnen, P., McDonald, A. J., & Pajonk, F. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2688-6 · Cited by 40
An adaptive stress response that confers cellular resilience to decreased ubiquitination
Hunt, L. C., Pagala, V., Stephan, A., Xie, B., Kodali, K., Kavdia, K., Wang, Y., Shirinifard, A., Curley, M., Graça, F. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43262-7 · Cited by 41
Altered Proteolysis and Global Gene Expression in Hepatitis B Virus X Transgenic Mouse Liver
Hu, Z., Zhang, Z., Kim, J. W., Huang, Y., & Liang, T. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1405-1413.2006 · Cited by 39
Lovastatin and simvastatin are modulators of the proteasome
Wójcik, C., Bury, M., Stokłosa, T., Giermasz, A., Feleszko, W., Młynarczuk-Biały, I., Pleban, E., Basak, G. W., Ōmura, S., & Jakóbisiak, M. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00044-3 · Cited by 38
Kessler, B. M., Glas, R., & Ploegh, H. L. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00100-1 · Cited by 38
Self-citationThe ubiquitin–proteasome system in HIV replication: potential targets for antiretroviral therapy
Klinger, P., & Schubert, U. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.1.61 · Cited by 43
ER-to-lysosome-associated degradation acts as failsafe mechanism upon ERAD dysfunction
Fasana, E., Fregno, I., Galli, C., Soldà, T., & Molinari, M. (2024) · EMBO Reports · doi:10.1038/s44319-024-00165-y · Cited by 37
Huai, J., Firat, E., Nil, A., Million, D., Gaedicke, S., Kanzler, B., Freudenberg, M. A., Endert, P. V., Köhler, G., Pahl, H. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801413105 · Cited by 37
Processing of Antigenic Peptides by Aminopeptidases
Hattori, A., & Tsujimoto, M. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.777 · Cited by 36
No essential role for tripeptidyl peptidase II for the processing of LCMV‐derived T cell epitopes
Basler, M., & Groettrup, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636372 · Cited by 35
Molinari, M., & Sitia, R. (2006) · Springer eBooks · doi:10.1007/3-540-28007-3_1 · Cited by 35
Molecular architecture and assembly mechanism of Drosophila tripeptidyl peptidase II
Rockel, B., Peters, J., Müller, S. A., Seyit, G., Ringler, P., Hegerl, R., Glaeser, R. M., & Baumeister, W. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504569102 · Cited by 34
Naylor, G. J. P., & Gerstein, M. (2000) · Journal of Molecular Evolution · doi:10.1007/s002390010084 · Cited by 34
Characterization of bortezomib-adapted I-45 mesothelioma cells
Zhang, L., Littlejohn, J., Cui, Y., Cao, X. X., Peddaboina, C. S., & Smythe, W. R. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-110 · Cited by 33
Oliveira, C. C., Querido, B. J., Sluijter, M., Derbinski, J., van der Burg, S. H., & van Hall, T. (2011) · European Journal of Immunology · doi:10.1002/eji.201141836 · Cited by 33
Conto, F. D., Pilotti, E., Razin, S. V., Ferraglia, F., Géraud, G., Arcangeletti, C., & Scherrer, K. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.13.2399 · Cited by 33
Stavropoulou, V., Vásquez, V., Cereser, B., Freda, E., & Masucci, M. G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.141 · Cited by 32
Proteasome Structures Affected by Ionizing Radiation
Pervan, M., Iwamoto, K. S., & McBride, W. H. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0032 · Cited by 32
Yokota, S. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10324 · Cited by 32
Zhou, Y., Ru, Y., Wang, C., Wang, S., Zhou, Z., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066634 · Cited by 31
Mechanisms Underlying Nonsteroidal Anti-Inflammatory Drug-Induced p27 Expression
Huang, Y., Chuang, L., & Hung, W. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1515 · Cited by 31
Bai, A.-L., Broen, J. B., & Forman, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80624-x · Cited by 41
Tripeptidyl-peptidase II expression and activity are increased in skeletal muscle during sepsis
Wray, C. J., Tomkinson, B., Robb, B. W., & Hasselgren, P. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00834-3 · Cited by 29
Structure and function of tripeptidyl peptidase II, a giant cytosolic protease
Rockel, B., Kopec, K. O., Lupas, A. N., & Baumeister, W. P. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.07.002 · Cited by 29
Kessler, B. M., Hong, X., Petrovic, J., Borodovsky, A., Dantuma, N. P., Bogyo, M. S., Overkleeft, H. S., Ploegh, H. L., & Glas, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211221200 · Cited by 28
Self-citationTomkinson, B. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1713 · Cited by 27
Ogiso, Y., Sugiura, R., Kamo, T., Yanagiya, S., Lü, Y., Okazaki, K., Shuntoh, H., & Kuno, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2324-2331.2004 · Cited by 27
Molecular Mechanisms of Host–Pathogen Interaction: Entry and Survival of Mycobacteria in Macrophages
Gatfield, J., & Pieters, J. (2003) · Advances in immunology · doi:10.1016/s0065-2776(03)81002-7 · Cited by 26
The ubiquitin/proteasome system in Epstein–Barr virus latency and associated malignancies
Dantuma, N. P., & Masucci, M. G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00101-3 · Cited by 26
Qi, L., & Ostrand‐Rosenberg, S. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010207.x · Cited by 28
Tripeptidyl-peptidase II: Update on an oldie that still counts
Tomkinson, B. (2019) · Biochimie · doi:10.1016/j.biochi.2019.05.012 · Cited by 26
Gileadi, U., Gallimore, A., van der Bruggen, P., & Cerundolo, V. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199907)29:07<2213::aid-immu2213>3.0.co;2-8 · Cited by 25
Serwold, T. F., & Shastri, N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4712 · Cited by 25
Jiao, J., Curley, M., Graça, F. A., Robles‐Murguia, M., Shirinifard, A., Finkelstein, D., Xu, B., Fan, Y., & Demontis, F. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111970 · Cited by 25
Role of tripeptidyl peptidase II in MHC class I antigen processing – the end of controversies?
Endert, P. V. (2008) · European Journal of Immunology · doi:10.1002/eji.200838181 · Cited by 24
Shumway, S. D., & Miyamoto, S. (2004) · Biochemical Journal · doi:10.1042/bj20031796 · Cited by 24
Osmulski, P. A., & Gaczynska, M. E. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00423-x · Cited by 24
Self-citationSmith, D. C., Gallimore, A., Jones, E., Roberts, B., Lord, J. M., Deeks, E. D., Cerundolo, V., & Roberts, L. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.99 · Cited by 24
The effect of proteasome inhibitors on mammalian erythroid terminal differentiation
Chen, C.-Y., Pajak, L., Tamburlin, J. H., Bofinger, D. P., & Koury, S. T. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00826-3 · Cited by 24
Fu, Q., Kim, S., Chen, H. X., Grill, S. P., & Cheng, Y. C. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23029-7 · Cited by 23
Tomkinson, B., & Eklund, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00734-1 · Cited by 22
Tomkinson, B., Laoi, B. N., & Wellington, K. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02783.x · Cited by 22
Preta, G., de Klark, R., & Glas, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.021 · Cited by 24
Self-citationHypericin?an inhibitor of proteasome function
Pajonk, F., Scholber, J., & Fiebich, B. L. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0933-8 · Cited by 22
Size Matters for the Tripeptidylpeptidase II Complex from Drosophila
Seyit, G., Rockel, B., Baumeister, W. P., & Peters, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602722200 · Cited by 21
Arcangeletti, C., Conto, F. D., Sütterlin, R., Pinardi, F., Missorini, S., Géraud, G., Aebi, U., Chezzi, C., & Scherrer, K. (2000) · European Journal of Cell Biology · doi:10.1078/0171-9335-00059 · Cited by 21
Foucrier, J., Grand, M. C., Conto, F. D., Bassaglia, Y., Géraud, G., Scherrer, K., & Martelly, I. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.7.989 · Cited by 21
Diekmann, J., Adamopoulou, E., Beck, O., Rauser, G., Lurati, S., Tenzer, S., Einsele, H., Rammensee, H., Schild, H., & Topp, M. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803441 · Cited by 20
Kato, M., Kuzuhara, Y., Maeda, H., Shiraga, S., & Ueda, M. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0408-4 · Cited by 19
Oliveira, C. C., Sluijter, M., Querido, B. J., OSSENDORP, F. A., van der Burg, S. H., & van Hall, T. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.006 · Cited by 18
Conto, F. D., Razin, S. V., Géraud, G., Arcangeletti, C., & Scherrer, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4556 · Cited by 17
Preta, G., de Klark, R., Chakraborti, S., & Glas, R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.133 · Cited by 20
Self-citationSompallae, R. R., Stavropoulou, V., Houde, M., & Masucci, M. G. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s882 · Cited by 19
Prosomes Form Sarcomere-like Banding Patterns in Skeletal, Cardiac, and Smooth Muscle Cells
Foucrier, J., Bassaglia, Y., Grand, M.-C., Rothen‐Rutishauser, B., Perriard, J., & Scherrer, K. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5212 · Cited by 16
Proteasome Inhibitors Therapeutic Strategies for Cancer
D’Alessandro, A., Pieroni, L., Ronci, M., D’Aguanno, S., Federici, G., & Urbani, A. (2008) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489209787002452 · Cited by 15
Firat, E., Tsurumi, C., Gaedicke, S., Huai, J., & Niedermann, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3269 · Cited by 15
The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress
Preta, G., de Klark, R., Gavioli, R., & Glas, R. (2010) · Journal of Oncology · doi:10.1155/2010/128478 · Cited by 15
Self-citationZhang, F., Muñoz, F. M., Sun, L., Zhang, S., Lau, S. S., & Monks, T. J. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.027 · Cited by 15
Hong, X., Lü, L., Künert, B., Naredla, R., Applequist, S. E., Grandien, A., & Glas, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4094 · Cited by 17
Self-citationRetractedChamberlain, K. L., Marshall, R. S., Jolliffe, N. A., Frigerio, L., Ceriotti, A., Lord, J. M., & Roberts, L. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805222200 · Cited by 14
Duensing, S. M., Darr, S., Cuevas, R. A., Melquiot, N. V., Brickner, A. G., Duensing, A. U., & Münger, K. (2010) · Genes & Cancer · doi:10.1177/1947601910389605 · Cited by 14
Zhang, J., Wong, J. T., Gao, G., & Luo, H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.11.056 · Cited by 13
Chapter 11 Proteinase families and their inhibitors
Mykles, D. L. (2001) · Methods in cell biology · doi:10.1016/s0091-679x(01)66012-6 · Cited by 13
Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands
Perez, M. A. S., Bassani‐Sternberg, M., Coukos, G., Gfeller, D., & Zoete, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02731 · Cited by 12
Stress regulation of the PAN–proteasome system in the extreme halophilic archaeon Halobacterium
Chamieh, H., Marty, V., Guetta, D., Perollier, A., & Franzetti, B. (2012) · Extremophiles · doi:10.1007/s00792-011-0421-0 · Cited by 11
Generation of major histocompatibility complex class I antigens
Yang, Y. M. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00050-3 · Cited by 11
Proteasomes Get By with Lots of Help from Their Friends
Yewdell, J. W., & Princiotta, M. F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00086-x · Cited by 10
Selective proteasome inhibitors as anti-inflammatory agents
Kalogeris, T. J., Gray, L. T., Laroux, F. S., Cockrell, A. S., Fuseler, J. W., Conner, E. M., Brand, S., & Grisham, M. B. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.9.1397 · Cited by 10
Ubiquitin- and proteasome-dependent pathway of protein degradation as an emerging therapeutic target
Wójcik, C. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.1.89 · Cited by 10
Metadata
- Authors
- Glas, R., Bogyo, M., McMaster, J. S., Gaczynska, M., & Ploegh, H. L.
- Affiliations
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- University of Utah (US)
- Corresponding author
- Ploegh, Hidde L.
- Venue
- Nature
- Published
- 1998-04
- Volume
- 392
- Issue
- 6676
- Pages
- 618-622
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W119139793
- Cited by
- 270
- References
- 29
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 3 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 5 · 2015: 2 · 2014: 4 · 2013: 8 · 2012: 6
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Swedish Foundation for International Cooperation in Research and Higher Education
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- proteasome, proteasome inhibitors, inhibitor resistance, protein degradation, protein quality control, cell growth, transcription factor activation, cell cycle regulation, MHC class I peptide presentation
- MeSH terms
- Adaptation, Physiological, Animals, Cysteine Endopeptidases, Hydrolysis, Multienzyme Complexes, Endopeptidases, Sulfones, Thermoplasma, Tumor Cells, Cultured, Ubiquitins, Histocompatibility Antigens Class I, Cysteine Proteinase Inhibitors, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.